Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal). (Q37536880)

From Wikidata
Jump to navigation Jump to search
scientific article published on 12 April 2012
edit
Language Label Description Also known as
English
Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal).
scientific article published on 12 April 2012

    Statements

    Clinical observation of patients with Fabry disease after switching from agalsidase beta (Fabrazyme) to agalsidase alfa (Replagal). (English)
    Kazuya Tsuboi
    Hiroshi Yamamoto
    12 April 2012
    779-786

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit